Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis.

Jing Ma; Huiqiu Zhang; Junsen Zhao; Menghan Su; Yingna Feng; Xiaoli Yuan; Dan Liu; Xiaomin Pang; Rongjuan Zhao; Juan Wang

doi:10.1038/s41598-024-79918-7

Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis.

Identifier:nobleid.org/w1/20260515/BAA2DF7F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BAA2DF7F.svg?ark=w1%2F20260515%2FBAA2DF7F)](https://nobleid.org/work/w1/20260515/BAA2DF7F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis.

Identifier:nobleid.org/w1/20260515/BAA2DF7F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BAA2DF7F.svg?ark=w1%2F20260515%2FBAA2DF7F)](https://nobleid.org/work/w1/20260515/BAA2DF7F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work